Bristol-Myers Squibb's strong profitability, significant drug growth, and low valuation provide great upside potential. Read ...

The markets face a baffling prospect: continual disruptions from the White House with potentially severe consequences.

We know that the economy moves in cycles. We know that a climbing stock market doesn’t climb forever. It is also no secret ...